BRR : 3814614
Tender Brief : Purchase Of Edl, Ecl And Other Medicines For Regional Referral Hospital, Nashik For Year 2023-24 , Inj. Atracurium Besylate 25Mg / 2.5Ml , Inj. Bupivacaine Hydrochloride 7.5 Milligram In 1 Milliliter, Dextrose Anhydrous 82.5 Milligram In 1 Milliliter Inj4 Ml , Inj. Etomidate Emulsion 2Mg / 10 Ml , Inj. Glycopyrrolate 0.2Mg/Ml-1 Ml , Inj Bupivacaine Hydrochloride 50Mg/10Ml , Isoflurane Amber-Colored Bottles.100 Ml , Inj. Ketamine Hcl 50 Mg/Ml - 10 Ml , Ketamine Hydrochloride Inj 10Mg/Ml , Inj. Lignocaine Or Lidocaine Or Xylocaine Hcl 0.01(1%) 30 Ml , Inj. Lignocaine Or Lidocaine Or Xylocaine... Read More
Tender Value
₹
Ref. Document
Contract Value
₹ 1
Submission Date
29-05-2023
Contract Date
08-07-2024
Completion Date
365 days
Participated Bidder List
17 No of Bidder(s)
| Sr No. | Bidder Name | Bid Analytics | Technical Bid | Financial Bid | AOC | Bid Value | Rank |
|---|---|---|---|---|---|---|---|
| 1 | cnet-technologies | Bid Analytics | 1 | L1 | |||
| 2 | cnet-technologies | Bid Analytics | |||||
| 3 | cnet-technologies | Bid Analytics | 1 | L1 | |||
| 4 | cnet-technologies | Bid Analytics | 1 | L1 | |||
| 5 | cnet-technologies | Bid Analytics | 1 | ||||
| 6 | cnet-technologies | Bid Analytics | 1 | L1 | |||
| 7 | cnet-technologies | Bid Analytics | 1 | L1 | |||
| 8 | cnet-technologies | Bid Analytics | 1 | L1 | |||
| 9 | cnet-technologies | Bid Analytics | 1 | L1 | |||
| 10 | cnet-technologies | Bid Analytics | 1 | L1 | |||
| 11 | cnet-technologies | Bid Analytics | 1 | L1 | |||
| 12 | cnet-technologies | Bid Analytics | 1 | L1 | |||
| 13 | cnet-technologies | Bid Analytics | 1 | ||||
| 14 | cnet-technologies | Bid Analytics | 1 | L1 | |||
| 15 | cnet-technologies | Bid Analytics | 1 | L1 | |||
| 16 | cnet-technologies | Bid Analytics | |||||
| 17 | cnet-technologies | Bid Analytics |
Work Detail
purchase of edl, ecl and other medicines for regional referral hospital, nashik for year 2023-24 , inj. atracurium besylate 25mg / 2.5ml , inj. bupivacaine hydrochloride 7.5 milligram in 1 milliliter, dextrose anhydrous 82.5 milligram in 1 milliliter inj4 ml , inj. etomidate emulsion 2mg / 10 ml , inj. glycopyrrolate 0.2mg/ml-1 ml , inj bupivacaine hydrochloride 50mg/10ml , isoflurane amber-colored bottles.100 ml , inj. ketamine hcl 50 mg/ml - 10 ml , ketamine hydrochloride inj 10mg/ml , inj. lignocaine or lidocaine or xylocaine hcl 0.01(1%) 30 ml , inj. lignocaine or lidocaine or xylocaine hcl 0.02 (2%) 30 ml , inj. xylocaine or lignocaine or lidocaine 5% heavy dextrose 75mg/ml, lignocaine hci 53.3mg/ml , lignocaine or lidocaine or xylocaine hcl 20mg, adrenaline or epinephrine 5mcg, per ml) 30ml inj , inj.mephentermine sulphate 35mg /ml-10 ml , injection propofo1% mct/lct in fat emulsion with oleic acid i.e. 10 mg/ml- 20 ml vial , injection propofo1% mct/lct in fat emulsion with oleic acid i.e. 10 mg/ml- 10 ml vial , sevoflurane amber-colored bottles.100 ml , sevoflurane amber-colored bottles.250 ml , oint lignocaine or lidocaine or xylocainehcl jelly 30 gm , inj. dexmedetomidine hydrochloride 200 mcg/2 ml (100 mcg/ml) , inj. diazepam 5 mg/ml - 2 ml , inj. midazolam hydrochloride 1 mg / ml , inj. midazolam hydrochloride 5 mg / ml , tab. diazepam 5 mg , inj. amikacine sulphate 500 mg - 2 ml , tab. amoxycillin i p 500 mg + clavulanic acid i p 125 mg - strip of 6 tablets , tab. azithromycin 500 mgaluminium blister - strip of 3 tab , cefixime tab 200 mg , inj. cepoforazone+salbactum 2gm inj. cepoferazone sodium 1 gm + sulbactum sodium 1 gm usp i.e. 2 gm , inj. cepoforazone+salbactum1gm inj. cepoferazone sodium 500 mg + sulbactum sodium 500 mg usp i.e. 1gm , inj. cefatoxime 1gm inj. cefotaxime sodium sterile powder 1 gm /vial , inj. cefatoxime 250 mg nj. cefotaxime sodiumsterile powder 250 mg/vial , inj. cefatoxime 500 mg nj. cefotaxime sodiumsterile powder 500 mg/vial , ceftazidime inj 1000 mg , inj. ceftrixone 500 mg , i. v. ciprofloxacin: each 100 ml contains : ciprofloxacin hcl eq. to ciprofloxacin 200 mg , water for injection q.s. affs/bfs/ffs technology , tab. ciprofloxacin 500 mg , inj. gentamycin 40 mg/ml - 2 ml amp/vial , i. v. ofloxacin- each 100 ml contain ofloxacin- 200 mg water for injection-q.s.affs/bfs/ffs technology , i. v, levofloxacin 5 mg/ml (500 mg) (as hemihydrate)., 100 ml flexible container, 100 ml fill (inj. levofloxacin 500 mg/100 ml)affs/bfs/ffs technology , inj. amoxycillin + clavunic acid 1.2gm inj. amoxycillin sodium 1000 mg + clavuanic acid as potasium salt 200 mg i.e. 1.2 gm (1.2 gm) in vial , linezolid inj 2 mg/ ml each - 100 ml contains linezolid 200 mg water for injection q.s. , tab linezolid 600 mg , inj. meropenam 1 gm - i.v. vial will deliver 1 g of meropenem and 90.2 mg of sodium as sodium carbonate (3.92 meq) , i v ornidazole 500mg /100ml , i v.metronidazole - 5mg / ml i. v. metronidazole 500 mg in 100 ml affs/bfs/ffs technology , tab. metronidazole 200 mg , tab. metronidazole 400 mg , tab. norfloxacin 400 mg aluminium blister - strip of 10 tab , tab. ofloxacillin 200 mg aluminium blister - strip of 10 tab , tab. levofloxacin 500 mg , teicoplanin inj. 200 mg , inj. vancomycin1 gm , inj. vancomycin 500 mg, , inj. pipercellin + tazobactum 4.5 gm , tab. glutamine powder , radiacure cream ( post - rt) , tegaderm ( sticking ) , inj. beracizumab 100mg / 400mg , inj. erithropoetine 40 cmcg , cap. hydrixy urea , protein powder , inj. cytocrystine 1mg , tab mycophenolate mofetil500 mg , tab tacrolimus 1 mg , inj. dactinomycin 0.5mg , inj filgrastim 150 mcg per vial-pfs , inj g-csf (granulocyte-colony stimulating factor) filgrastim 300 mcg per vial-pfs/gmcsf , inj. mitomycin c 10 mg in vial , inj. paclitaxel 30 mg in 5 ml , inj. paclitaxel 200 mg , inj. paclitaxel 300 mg , inj. vincristine 1 mg per ml , inj. phenytoin sodium 50 mg/ml - 2 ml (diphenyl hadantoin sodium ) , tab. amlodepin besylate 5 mg aluminium blister - strip of 10 tablets , tab. atenolol 50 mg aluminium blister - strip of 14 tablets , tab. enalaprile maleate 5 mg , tab. frusemide 40 mg aluminium blister - strip of 10 tab , hydralazine hydrochloride injection, (20 mg/ml) , inj clonidine hcl 100 mcg per 1 ml - 1 ml , inj. labetalol hcl 20 mg , tab losartan potassium 50 mg , tab. olmisartan medoxomil 20mg , injection metoprolol tartrate - each vial contain metoprolol tartrate 1 mg per ml i.e. 5 mg/5 ml , tab metoprolol 25 mg , tab metoprolol 50 mg , cap.nifedepine 20 mg aluminium blister - strip of 10 capsule , tab. prazocin hcl 2.5 mg , tab. prazocin hcl 5 mg , tab ramipril 2.5 mg , tab ramipril 5 mg , tab clonidine hcl 0.1 mg i.e. 100mcg , tab carvedilol 12.5mg , tab carvedilol 3.125 mg , tab carvedilol 6.25 mg , telmisartan tab 40 mg , telmisartan tab 80 mg , inj. aminodarone 150mg/3ml ampoules i.e. 50 mg per ml , tab. amidarone 200 mg , inj. atropine sulphate0.6 mg/ml - 1 ml amp , inj. adinosine , inj. heparin sodium 25000 i u/ml - 5 ml vial , low molecular weight heparin (daltiparin) 2500 iu p f s , inj diltiazem 5 ml - i v each ml contains:diltiazem hcl 5mg/ml , tab diltiazem hcl 30mg , tab diltiazem hcl 60 mg , inj. glyceryl trinitrate 5mg/ml-5 ml amp , tab. glyceryl trinitrate 2.6 mg , tab. isosorbide dinitrate 5 mg aluminium blister - strip of 10 tablets , tab isosorbide-5-mononitrate 10 mg , inj. nitroglycerine 5 ml each ml to contain : nitroglycerine trinitrate 5 mg , tab nicorandil 5 mg , inj.streptokinase 15 lacs/vial , inj. nor adrenaline 4 mg in 2 ml ie. 2 mg per ml , inj. digoxin 0.25 mg per ml i.e. .5 mg in 2 ml , tab. digoxin 250 microgram i.e.0.25 mg , inj. dobutamine 50 mg/ml - 5 ml ampoule(i.e.250mg) , inj. dopamine hcl 200 mg/5 ml vial (40 mg/ml) , tab. atrovastatin 10 mg , tab. atrovastatin 20 mg , tab. atrovastatin 40 mg , tab. atrovastatin 80mg , rosuvastatin tab 10 mg , rosuvastatin tab 20 mg , tab. aspirin (acetylsalicylic acid) 75 mg aluminium blister of 14 tablets , tab. aspirin (acetylsalicylic acid) 150 mg aluminium blister of 14 tablets , tab clopidrogel 75 mg , inj. epinephrine hydrochloride or hydrogen tartarate in 1 mg / 1ml ampoule/ inj. adrenaline bitartarate 1 : 1000 w/v 1 ml. , tab. cetrizine di hydrochloride 10 mg aluminium blister - strip of 10 tablets , tab methyl cobalmine 1500 mcg , tab methyl cobalmine 500 mcg , inj. cyanocobalamin (vitamine b 12 ) 1000mcg/ml; soln for im or sc inj; contains benzyl alcohol.- 10ml , tab folic acid 5 mg. , feerous sulphate 333-335 mg (equivalent to 100 mg of elemental iron) + folic acid i p 0.5 mg , enteric coated , ferrous sulphate i p equivalent to 45 mg of elemental iron + folic acid 4oo mcg, junior pink colour , sugar coated tab , budenoside repsules , inj. etophyllin 169.4 mg + theophyllin 50.6 mg in 2 ml - 2 ml , ipratropium bromide 250mcg/ml - 15 ml , levo salbutamol respiratory solution 0.0625 mg/ml , tab. etophyllin 231 mg + theophyllin 69 mg s r aluminium blister - strip of 10 tabs , inj. dexamethasone sodium phosphate 4 mg/ml - 2 ml vial im/iv - , inj. hydrocortisone sodium succinate 100mg; , inj methyl prednisolone acetate 1gm/ml - , inj. methylprednisolone sodium succinate -500 mg each 2 ml (when mixed) contains methylprednisolone sodium succinate equivalent to 500 mg methylprednisolone; , tab. prednesolone 10 mg aluminium blister - strip of 10 tab , tab. prednesolone 20 mg aluminium blister - strip of 10 tab , capcalcitriol 0.25 & .5 mcg , inj. recombient erythropoietin 2000 iu per vial , inj. recombient erythropoietin 4000 iu per vial , highly purified human neutral insulin 40iu/ml - 10 ml , tab tamoxifen citrate 20mg , tab thyroxine sodium 100 mcg- 100 tablets in amber colour glass bottle , tab thyroxine sodium 50 mcg- 100 tablets in amber colour glass bottle , tab. gliclazide 80mg , tab glimepiride 1 mg , tab glimepiride 2 mg , tab. metformin 500 mg , tab voglibose 0.2mg , highly purified bovine porcine isophane insulin susp 40 i.u./ml rapid actiing insulin (or neutral protamine hagedorn) (also known as humulin n, novolin n, novolin nph, nph iletin ii, and isophane insulin), , tab. dicyclomine 10 mg , tab. bisacodyl 5 mg , cap.omperazole 20 mg aluminium blister - strip of 10 capsule , cap.omperazole 40 mg aluminium blister - strip of 10 capsule , inj. pantaprazole 40 mg / 10 ml , pantoprazole tab. 40mg , inj. ranitidine hcl 25 mg/ ml - 2 ml ampoule each 1 ml of aqueous solution contains ranitidine 25 mg (as the hydrochloride); phenol 5 mg as preservative; and 0.96 mg of monobasic potassium phosphate and 2.4 mg of dibasic sodium phosphate as buffers. , sy. antacid each 5 ml contains aluminium hydroxide 250 mg + magnesium hydroxide 250 mg + dimethicone 50 mg , metoclopramide hcl 5 mg/ml , metoclopramide hcl 10 mg , tab. ondansetron 4 mg , inj. promethazine hydrochloride 25 mg/ml im/iv each ml contains either 25 mg promethazine hydrochloride with 0.1 mg edetate disodium, 0.04 mg calcium chloride, 0.25 mg sodium metabisulfite, and 5 mg phenol in water for injection.- 2 ml ampoules i. m./i. v , inj betamethasone 4mg/ml , inj. magenesium sulphate50 % w/v - 2 ml i.e. each ml contain 500 mg magnesium sulphate per ml , inj. ethamsylate 125 mg/ml - i.e. 250 mg in 2 ml ampoule , inj protamine sulfate injection, 50 mg (10 mg/ml, 5 ml) in a single dose flip-top vial , tab tranexemic acid500 mg , inj. menadion bisulphate trihydrate 10 mg/ml (aqueous)(vitamin k ) - 1 ml , tab warfarin sodium 2 mg , tab warfarin sodium 5mg , tranexemic acid inj 1 gm , inj. artesunate 60 mg vial , inj. succinylcholine chloride 50 mg in each ml - 10 ml vial (suxamethonium chloride) , inj. vecuronium bromide 10 mg per ampoule of 10 ml , inj. vecuronium bromide 4 mg per ampoule of 2 ml , inj. diclofenac sodium 75 mg/ml - 1 ml amp iv/im , tab. diclofenac sodium 50 mg aluminium blister - strip of 10 tablets , inj. paracetamol 150 mg/ml - 2 ml , inj. paracetamol 10 mg / ml i.e. 100 mg in- 100 ml , inj. paracetamol 150 mg/ml - 10 ml , tab paracetamol 500mg , tab acelofenac 100 mg , inj. fentanyl 50mcg/ml , inj. pentazocin lactate 30 mg/ml - 1 ml ampoule , inj. trammadol 50 mg / ml - 2 ml ampoule , tab. tramadol 50 mg , tab torsemide 10 mg , tab torsemide 20 mg , tab spironolactone 25 mg aluminium blister - strip of 10 tab , tab chlorthalidone 12.5mg , tab hydrochlorothiazide 12.5 mg , tab hydrochlorothiazide 25 mg , inj. frusemide - 2 ml each 1 ml contains 10 mg furosemide , sodium bi carbonate tab 300 mg , di sodium hydrogen citrate 100 ml , fluconazole tab 150mg , allopurinol tab 100 mg , tab hydroxyurea capsules 500 mg , inj. pralidoxime chloride 1g/ 20 ml , inj. pralidoxime chloride 500 mg/ 20 ml , tetanus toxoid - each 0.5 ml human dose contains:tetanus toxoid = lf, adsorbed on aluminium phosphate = 1.5 mg(aipo4) thiomersal 0.01% as presevative (vaccine fulfils the i.p. requirement for tetanus toxoid (adsorbed) , tetanus toxoid - each 5 ml human dose contains:tetanus toxoid = lf, adsorbed on aluminium phosphate = 5 ml vial mg(aipo4) thiomersal 0.01% as presevative (vaccine fulfils the i.p. requirement for tetanus toxoid (adsorbed) , i v m v i retinol, ergocalciferol, alpha-tocopherol acetate, dl-, phytonadione, ascorbic acid, niacinamide, riboflavin phosphate sodium, thiamine, pyridoxine hydrochloride, dexpanthenol, biotin, folic acid and cyanocobalamin injection, solution , tab. ascorbic acid 500 mg , each ml contains: thiamine hydrochloride 100 mg, riboflavin 5’ phosphate sodium 2 mg, pyridoxine hydrochloride 2 mg, dexpanthenol 2 mg, niacinamide 100 mg, with benzyl alcohol 2% as preservative, in water for injection. sodium hydroxide and/or hydrochloric acid may have been used to adjust ph , intravenous 10% amino acids solution -paediatric specific intravenous 10% amino acids solution with taurine, special conditionally essential amino acid. - 100 ml , tab. vitamin b complex(therupetic ) n f i , tab calcium carbonate-1.25 gmi.e.1250 mg vit d3- 250 iu, , inj. calcium gluconate 100 mg/ml(w/v)10 ml , tab l ornithin - l aspartate , inj. darbepoetin alfa- 25 / 40/60 mcg , sodium chloride 0.065% w/v benzakonium chloride solution (as preservative) 0.02%w/v sterile isotonic aqueous buffered base q.s. , i. v. . dextrose anhydrous 10%, water for inj. qs. 500 ml - affs/bfs/ffs technology , i. v. dextrose 5% isotonic w/v affs/bfs/ffs technology , i.v. 25% dextrose 100 cc affs technology i. v. dextrose 25% w/v - 100ml affs/bfs/ffs technology , i. v. dextrose 5% in normal saline 0.9% ( i. e. glucose with sodium chloride5% glucose, 0.9% sodium chloride (equivalent to 150 mmol/l na+ and150 mmol/l cl-); 5% glucose, 0.45% sodium chloride (equivalent to 75 mmol/l na+ and 75 mmol/l cl-w/v )affs/bfs/ffs technology , gluteraldehyde solution 2% activation non staining non restoring 5 ltr jar , hydrogen peroxide 20 volume 6% w/v 500 ml , i.v. mannitol 20% 100 ml bottle affs technology i.v. mannitol 20% 100 ml (20 mg / ml ) affs/bfs/ffstechnology , multiple electrolytes & dextrose injection type iii ip for maintenance:maintenance replacement soluation with 5% dextroseeach 100 ml contains: dextrose anhydrous i.p. 5 gm ,potassium chloride i.p. 0.13 gm , magnesium chloride i.p. 0.031 gm , dipotassium hydrogen phosphate 0.026 gm , water for injection ip q.s. affs/bfs/ffstechnology , multiple electrolytes & dextrose injection type iii ip for maintenance:maintenance replacement soluation with 5% dextroseeach 100 ml contains: dextrose anhydrous i.p. 5 gm , sodium chloride i.p. 0.1 gm, potassium chloride i.p. 0.15 gm , sodium acetate i.p.0.28 gm , dipotassium hydrogen phosphate 0.13 gm , water for injection ip q.s. affs/bfs/ffstechnology , inj. potasium chloride 150 mg/ml 10 ml , i. v. ringers lactate (sodium lactate, compound solution ) each 100ml to contain: lactic acid 0.24 ml., sod.chl. 0.6 gm, potassium chloride 0.04 gm, calcium chloride 0.027 gm. water for injection q.s. calculated osmolarity –280 mos/l(approx) concentration of electrolytes (in moles/lit.)- sodium 131, potassium 5, calcium 2, bicarbonate (as lactate) 29, chloride 111.affs/bfs/ffs technology , inj. sodabicarbonate 7.5 mg/ml (7.5%) - 10 ml sodium bicarbonate,nonpyrogenic solution of sodium bicarbonate, in water for injection, it contains no antimicrobial agent. composition, osmolarity, ph and ionic (nahco3) (g/l)osmolarity (mosmol/l) (calc.)*ph sodium bicarbonate , i. v. sodium chloride (normal saline)0.9% isotonic (equivalent to na+ 154 mmol/l,cl- 154 mmol/l).w/v affs/bfs/ffs technology , i. v. sodium chloride (normal saline)0.9% isotonic (equivalent to na+ 154 mmol/l,cl- 154 mmol/l).w/v affs/bfs/ffs technology , i. v. sodium chloride (normal saline) 0.9% isotonic (equivalent to na+ 154 mmol/l,cl- 154 mmol/l).w/v affs/bfs/ffs technology , i. v. sodium chloride (normal saline)0.9% isotonic glass bottle (equivalent to na+ 154 mmol/l,cl- 154 mmol/l).w/v affs/bfs/ffs technology , i. v. sodium chloride (normal saline)3000ml ( 3 ltr. ) (equivalent to na+ 154 mmol/l,cl- 154 mmol/l).w/v affs/bfs/ffs technology , i. v. sodium chloride (normal saline)3 % isotonic (equivalent to na+ 154 mmol/l,cl- 154 mmol/l).w/v affs/bfs/ffs technology , i. v. sodium chloride (normal saline)45 % w/v (equivalent to na+ 154 mmol/l,cl- 154 mmol/l).w/v affs/bfs/ffs technology , i. v. glycine irrigation solution i. p. 1.5% w/v 3000 ml , i. v. multiple electrolyte - kabilyte 500ml , i. v. kabivein peripheral emulsion for infusion 1920ml ( 3 chember bag containing glucose solution, amino acid solution, and fat imulsion) , inj cyclosporine 100 mg/ml - 50 ml , tab cyclosporine 50 mg , tab deferasirox 100 mg , tab deferasirox 250 mg , tab deferasirox 400 mg , tab deferasirox 500 mg , inj desferrioxamine mesylate 500 mg , 4 % succinylated gelatin(gelofusine) , albumin (human) 20% is supplied in 10 g in 50 ml infusion bottle o r 20 g in 100 ml infusion bottle , inj. neostigmine each ml of the 1:2000 concentration contains neostigmine methylsulfate 0.5 mg, methylparaben 1.8 mg and propylparaben 0.2 mg (used as preservatives), in water for injection q.s.ph (range 5.0 - 6.5) adjusted, when necessary, with sodium hydroxide - 1 ml usp , iohexol 300mg iodine/ml or iohexol 350mg iodine/ml glass vials of 100ml , iopromide 300 mgi/ml or iopromide 370 mgi/ml glass vials of 50ml , clotrimazole mouth paint 1% w/v - 15 ml , glycerin 500 ml glass bottle , heparine jelly 200 iu per gm - 20 gm , oint. povidone iodine 5%w/w 15 gm , povidone-iodine 5% w/v solution , povidone-iodine 5% w/v solution , tincture iodine - active ingredientsiodine 2% sodium iodide 2.4% alcohol 47% , benzylkonium chloride 50% w/v . - 500 ml , antiseptic solution containing = cetrimide 3% w/v chlorohexidine 1.5% w/v = 5 ltr jar , dichlorometxynol 1.88% + terpineol 2% ( soap solution base) 5 ltr jar , formaldehyde 500 ml , formaldehyde 5 ltr. , sodium hypochlorite sol. contains not less than 4% and not more than 6% sodium hypochlorite. , povidone iodine 7.5% w/v topical solutionscrub 500 ml , surgical spirit with methyl salicylate, diethyl phthalate and castor oil in denatured alcohol , tincture benzoin 500 ml , sterile water for injection.10 ml , inj. cefuroxime 1.5gm/vial , inj vitamin d3 (cholecalciferol) 60,000 iu / g , inj. phytomenadione 1mg /ml , inj l ornithin - l aspartate , pheniramine maleate inj 22.75mg/2ml , inj. eptifibatide100 ml , inj. mayopyrolate ( glycopyrolate 0.5 mg + neostagmin 2.5mg ) , inj. levera500 mg/ 5 ml ( levetiracetam 500 mg) , tab. levera 500mg , tab. levera 750mg , inj. papavarine hcl2 ml 30 mg , inj. torsemide2 ml amp. , syp. cyclosporine oral suspension100 mg /ml, 50ml , tab.perindopril erbumine 4 mg plus indepamide 1.25 mg , tab. perindopril 4 gm , tab. gasex , tab. cystone , tab. indopamidesr 1.5 mg + amlodepine besylate 5 mg ( corolon ) , tab. azathioprime 50mg (azoran ) , tab. prasugrel 10 mg , tab. ubidecorenone usp 180 mg ( renoque 180 mg) , tab. metolazone 5 mg , tab. ranolazine 500 mg , tab. acetylcystine 150 mg + tourine 500 mg , tab. cardevelol 25 mg , tab. cardevelol 50 mg , tab. tamsulosin hydrochloride ip 0.4mg , tab. tamsulosin hydrochloride 0.4 mg + dutasterideip 0.5mg , frusemide 20mg + spironalactone 50mg , citrosterile5ltr. can , glucometer ( accu-check )( performa ) , liquid soap , inj. hepatatis b 10ml , tab. ubidecarenone ( renoque 180mg ) , inj. xylocard , inj. bortazomib 2mg , inj. fosaprepitant 150mg , inj. granisetron , radiocare cream 150gm , tab. alphaketoanolege , inj. erbitax 100mg , inj. harceptine 150 mg , tab. prasugrel 10 mg , syp. sylimarim 100ml , tab. alphaketoanolege , tab.ticagrelol 90 mg , inj.clindamycine 600 mg , absorbent cotton wool 500 gm net , glucometer strip accu-check ( performa ) , stabilized hydrogen peroxide 11 % w/v + diluated silver nitrate solution 0.01% w/v , mecetronium and alchohol dry hand rub ( saniscrub m )
View Original Notice/Document
Result Documents
Tender Documents
Disclaimer
We takes all possible care for accurate & authentic tender information. However users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender
✦ ✦ ✦
Awarded Bidder(s)
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
Similar Tenders Results